As no non-Jewish sporadic case (even the adopted individuals) reached the 10% combined threshold even at the time of diagnosis, this supports the hypothesis that, in Western populations, the rates of BRCA1/2 mutations even in early-onset breast cancer cases without a FH are low. This evidence concerns the gene BRCA1 and breast carcinoma.